- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 655064
Total 1238 results
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteAustria, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSchizophrenia | Alzheimer DiseaseUnited States
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Boehringer IngelheimCompleted
-
Children's Hospital of PhiladelphiaPhilips RespironicsCompletedObstructive Sleep ApneaUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNeoplasms | NUT CarcinomaUnited States, Spain, Belgium, Germany, France, Korea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | Renal InsufficiencyGermany
-
Boehringer IngelheimCompletedHealthy | Chronic Kidney DiseaseGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteUnited States
-
Boehringer IngelheimCompletedWet Macular DegenerationAustria, Germany, Hungary
-
Boehringer IngelheimCompleted
-
Baxalta now part of ShireCompletedRecombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand RegimenHemophilia A | Hemophilia BJapan, Russian Federation, Spain, United States, Poland, Romania, Serbia, Taiwan, Ukraine
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Pulmonary Fibrosis
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | Renal InsufficiencyGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminatedSafety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisArthritis, RheumatoidUnited States, Belgium, Bulgaria, Germany, Greece, Netherlands, Poland, Portugal, Spain
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Dr Phillip J BuckhurstBMI Southend HospitalCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | AsthmaUnited Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimNot yet recruiting